Delivery Order SPE2DB25D3006-SPE2DB25FXHPS
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for the supply of 4,567,304,075 units of the medication ESBRIET 801 MG TABLET 90S. The contract has an ultimate completion date of March 11, 2025 and was awarded on February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed-price delivery order contract covers the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price Delivery Order contract is for the supply of ESBRIET 801 MG TABLET 90S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price Delivery Order contract is for the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and was awarded on March 20, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,277.85 firm fixed price delivery order contract is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order contract is for the supply of ESBRIET 801 MG TABLET 90S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 16, 2024 and was awarded on November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,623 firm fixed-price delivery order is for the supply of ESBRIET 801 MG tablets, with an ultimate completion date of November 26, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price Delivery Order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXHPSDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm-fixed-price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is one of the orders placed against that IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/21/25 |